Patients with CKD have a 56% higher prevalence of severe mental health disorders such as schizophrenia, bipolar disorder, or ...

Sotagliflozin, a dual SGLT1/2 inhibitor, reduces cardiovascular events in people with diabetic kidney disease — ischemic benefits not observed in trials of selective SGLT2 inhibitors.

Landmark new blood test could predict risk of cancer and other major diseases - A new study found that one test could pick up future problems and how they create issues in another part of the body ...